Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024)
Harvard Bioscience (HBIO) posted quarterly Change in Acquisitions & Divestments of $1.4 million for Q3 2024, little changed quarter-over-quarter from $1.4 million in Q2 2024.
Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024) Analysis & Trends
Harvard Bioscience (HBIO) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $1.4 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $1.4 million; the TTM figure through Jun 2025 stood at $1.4 million (down 26.12% YoY), while the FY2024 annual figure was $1.9 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments held at $1.4 million in Q3 2024 per HBIO's latest filing, from $1.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $1.4 million in Q2 2024 and bottomed at $495000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 495,000.00 |
| Mar 31, 2024 | 495,000.00 |